Liam Cornell

539 total citations
7 papers, 414 citations indexed

About

Liam Cornell is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Liam Cornell has authored 7 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Liam Cornell's work include Cancer therapeutics and mechanisms (2 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer Treatment and Pharmacology (2 papers). Liam Cornell is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer Treatment and Pharmacology (2 papers). Liam Cornell collaborates with scholars based in United States, United Kingdom and Australia. Liam Cornell's co-authors include Geoffrey I. Shapiro, Seth A. Wander, Nikhil Wagle, Tanvi H. Visal, Catharine M. Chase, Paul S. Russell, William H. Kitchens, Robert B. Colvin, Shuichiro Uehara and Joren C. Madsen and has published in prestigious journals such as Gut, Clinical Cancer Research and Kidney International.

In The Last Decade

Liam Cornell

7 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liam Cornell United States	5	210	181	117	73	58	7	414
Rico D. Bense Netherlands	8	177 0.8×	298 1.6×	166 1.4×	141 1.9×	34 0.6×	9	508
Sue Fuggle United Kingdom	4	202 1.0×	69 0.4×	62 0.5×	262 3.6×	103 1.8×	7	390
Roxana Azimi United States	3	167 0.8×	347 1.9×	112 1.0×	74 1.0×	39 0.7×	7	501
Sandy Larson United States	8	133 0.6×	170 0.9×	94 0.8×	92 1.3×	21 0.4×	12	402
C L Tso United States	10	305 1.5×	256 1.4×	213 1.8×	73 1.0×	71 1.2×	13	649
Taichi Isobe Japan	12	325 1.5×	186 1.0×	51 0.4×	209 2.9×	27 0.5×	34	490
Takahiko Yasuda Japan	12	269 1.3×	79 0.4×	21 0.2×	101 1.4×	19 0.3×	33	465
Sarah Croessmann United States	13	217 1.0×	219 1.2×	136 1.2×	239 3.3×	17 0.3×	26	492
Luke B. Fletcher United States	8	168 0.8×	64 0.4×	39 0.3×	51 0.7×	14 0.2×	16	328
Ruud van der Noll Netherlands	12	318 1.5×	213 1.2×	99 0.8×	59 0.8×	50 0.9×	20	463

Countries citing papers authored by Liam Cornell

Since Specialization

Citations

This map shows the geographic impact of Liam Cornell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liam Cornell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liam Cornell more than expected).

Fields of papers citing papers by Liam Cornell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liam Cornell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liam Cornell. The network helps show where Liam Cornell may publish in the future.

Co-authorship network of co-authors of Liam Cornell

This figure shows the co-authorship network connecting the top 25 collaborators of Liam Cornell. A scholar is included among the top collaborators of Liam Cornell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liam Cornell. Liam Cornell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Cornell, Liam, Seth A. Wander, Tanvi H. Visal, Nikhil Wagle, & Geoffrey I. Shapiro. (2019). MicroRNA-Mediated Suppression of the TGF-β Pathway Confers Transmissible and Reversible CDK4/6 Inhibitor Resistance. Cell Reports. 26(10). 2667–2680.e7. 108 indexed citations

2.

Haines, Eric, Ting Chen, Naveen Kommajosyula, et al.. (2018). Palbociclib resistance confers dependence on an FGFR-MAP kinase-mTOR-driven pathway inKRAS-mutant non-small cell lung cancer. Oncotarget. 9(60). 31572–31589. 37 indexed citations

3.

Cornell, Liam, Joanne M. Munck, Clara Alsinet, et al.. (2014). DNA-PK—A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival. Clinical Cancer Research. 21(4). 925–933. 69 indexed citations

4.

Munck, Joanne M., Michael A. Batey, Yan Zhao, et al.. (2012). Chemosensitization of Cancer Cells by KU-0060648, a Dual Inhibitor of DNA-PK and PI-3K. Molecular Cancer Therapeutics. 11(8). 1789–1798. 99 indexed citations

5.

Cornell, Liam, Joanne M. Munck, Nicola J. Curtin, & Helen L. Reeves. (2012). PTU-042 DNA-PK or ATM inhibition inhibits non-homologous end joining and enhances chemo- and radio sensitivity in hepatocellular cancer cell lines. Gut. 61(Suppl 2). A201.1–A201. 1 indexed citations

6.

Patel, Tejas, Liam Cornell, & M. Wolf. (2008). Renal metastases. Kidney International. 73(3). 370–370. 3 indexed citations

7.

Kitchens, William H., Catharine M. Chase, Shuichiro Uehara, et al.. (2007). Macrophage Depletion Suppresses Cardiac Allograft Vasculopathy in Mice. American Journal of Transplantation. 7(12). 2675–2682. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact